Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2022-04-04 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (529 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled '2022_09_Stock_buyback_program'. This indicates the document itself is an announcement about the availability of a report, not the report content. The subject matter is a 'stock buyback program,' which directly corresponds to the definition of 'Transaction in Own Shares' (POS). Since this is an announcement pointing to the full details, it should be classified as a Report Publication Announcement (RPA) based on the 'MENU VS MEAL' rule, as it is announcing the publication of the transaction details, although POS is the underlying topic. However, given the specific nature of the content (buyback program), POS is the most accurate topic classification, and RPA is used when the content is purely a pointer. In this case, the content is a pointer to a POS document. I will prioritize the specific topic (POS) over the announcement format (RPA) because the topic is clearly defined, and POS documents often include a brief summary before linking to the full filing. Re-evaluating against the definitions: POS is 'Report of the company buying back or selling its own shares'. Since the title is 'Transactions under Novozymes’ stock buyback program' and it points to the details, POS is the most fitting category for the subject matter, even if it's a short announcement.
2022-04-04 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a report detailing specific transactions made by Novozymes under its stock buyback program, including a summary table of daily transactions and an appendix with granular trade data. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2022-04-04 English
Share Issue/Capital Change 2022
Share Issue/Capital Change Classification · 99% confidence The document text is extremely short (529 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled '2022_08_Stock_buyback_program'. This indicates the document itself is an announcement about the availability of a report, not the report content. The subject matter is a 'stock buyback program,' which directly corresponds to the definition of 'Transaction in Own Shares' (POS). However, due to the 'MENU VS MEAL' rule, since this is an announcement pointing to the actual filing, it should be classified as a Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS) if RPA is too specific. Given the clear nature of announcing a specific transaction report, RPA is the most appropriate classification based on the rule structure, as it announces the publication of a report/transaction details.
2022-03-28 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed report of Novozymes' stock buyback program, providing specific transaction data, dates, volumes, and prices for the period of March 21st to March 25th, 2022. This falls under the category of a company reporting on its own share repurchases, which is explicitly defined as 'Transaction in Own Shares' (POS).
2022-03-28 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program' by Novozymes, providing accumulated figures, daily transaction details (number of shares, average price, transaction value), and referencing the relevant regulatory framework (Market Abuse Regulation). This content directly relates to the company managing its own shares, which aligns perfectly with the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), a full annual report (10-K), or a management discussion (MDA).
2022-03-21 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a very short announcement (529 characters) regarding a stock buyback program. It explicitly states 'Please read the full announcement in the attached PDF' and provides a link to the attachment. According to the 'Menu vs Meal' rule, this is an announcement of a report/transaction rather than the transaction report itself, and it specifically functions as a notification of a document publication.
2022-03-21 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.